The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Niteesh K. Choudhry

Division of Pharmacoepidemiology and Pharmacoeconomics

Brigham and Women's Hospital and Harvard Medical School

Boston

Massachusetts. Electronic address:

[email]@partners.org

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. Electronic address:. 2007 - 2012
  • Harvard Medical School, USA. 2010
  • Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts, USA. 2006 - 2007
  • Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, Massachusetts, USA. 2006

References

  1. The impact of reducing cardiovascular medication copayments on health spending and resource utilization. Choudhry, N.K., Fischer, M.A., Avorn, J.L., Lee, J.L., Schneeweiss, S., Solomon, D.H., Berman, C., Jan, S., Lii, J., Mahoney, J.J., Shrank, W.H. J. Am. Coll. Cardiol. (2012) [Pubmed]
  2. Full coverage for preventive medications after myocardial infarction. Choudhry, N.K., Avorn, J., Glynn, R.J., Antman, E.M., Schneeweiss, S., Toscano, M., Reisman, L., Fernandes, J., Spettell, C., Lee, J.L., Levin, R., Brennan, T., Shrank, W.H. N. Engl. J. Med. (2011) [Pubmed]
  3. The cost-effectiveness of C-reactive protein testing and rosuvastatin treatment for patients with normal cholesterol levels. Choudhry, N.K., Patrick, A.R., Glynn, R.J., Avorn, J. J. Am. Coll. Cardiol. (2011) [Pubmed]
  4. At Pitney Bowes, value-based insurance design cut copayments and increased drug adherence. Choudhry, N.K., Fischer, M.A., Avorn, J., Schneeweiss, S., Solomon, D.H., Berman, C., Jan, S., Liu, J., Lii, J., Brookhart, M.A., Mahoney, J.J., Shrank, W.H. Health. Aff. (Millwood) (2010) [Pubmed]
  5. Measuring concurrent adherence to multiple related medications. Choudhry, N.K., Shrank, W.H., Levin, R.L., Lee, J.L., Jan, S.A., Brookhart, M.A., Solomon, D.H. Am. J. Manag. Care (2009) [Pubmed]
  6. Drug company-sponsored patient assistance programs: a viable safety net?. Choudhry, N.K., Lee, J.L., Agnew-Blais, J., Corcoran, C., Shrank, W.H. Health. Aff. (Millwood) (2009) [Pubmed]
  7. Cost-effectiveness of providing full drug coverage to increase medication adherence in post-myocardial infarction Medicare beneficiaries. Choudhry, N.K., Patrick, A.R., Antman, E.M., Avorn, J., Shrank, W.H. Circulation (2008) [Pubmed]
  8. Rationale and design of the Post-MI FREEE trial: a randomized evaluation of first-dollar drug coverage for post-myocardial infarction secondary preventive therapies. Choudhry, N.K., Brennan, T., Toscano, M., Spettell, C., Glynn, R.J., Rubino, M., Schneeweiss, S., Brookhart, A.M., Fernandes, J., Mathew, S., Christiansen, B., Antman, E.M., Avorn, J., Shrank, W.H. Am. Heart J. (2008) [Pubmed]
  9. Comparison of the impact of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management trial on prescribing patterns: a time-series analysis. Choudhry, N.K., Zagorski, B., Avorn, J., Levin, R., Sykora, K., Laupacis, A., Mamdani, M. Ann. Pharmacother (2008) [Pubmed]
  10. The economic consequences of non-evidence-based clopidogrel use. Choudhry, N.K., Levin, R., Avorn, J. Am. Heart J. (2008) [Pubmed]
  11. Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patients. Choudhry, N.K., Setoguchi, S., Levin, R., Winkelmayer, W.C., Shrank, W.H. Pharmacoepidemiol. Drug. Saf (2008) [Pubmed]
  12. Should patients receive secondary prevention medications for free after a myocardial infarction? An economic analysis. Choudhry, N.K., Avorn, J., Antman, E.M., Schneeweiss, S., Shrank, W.H. Health. Aff. (Millwood) (2007) [Pubmed]
  13. Statins in elderly patients with acute coronary syndrome: an analysis of dose and class effects in typical practice. Choudhry, N.K., Levin, R., Winkelmayer, W.C. Heart (2007) [Pubmed]
  14. Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis. Choudhry, N.K., Anderson, G.M., Laupacis, A., Ross-Degnan, D., Normand, S.L., Soumerai, S.B. BMJ (2006) [Pubmed]
  15. Warfarin prescribing in atrial fibrillation: the impact of physician, patient, and hospital characteristics. Choudhry, N.K., Soumerai, S.B., Normand, S.L., Ross-Degnan, D., Laupacis, A., Anderson, G.M. Am. J. Med. (2006) [Pubmed]
 
WikiGenes - Universities